Internal Medicine · Pittsburgh, PA
NPI
1508209974
Since 2013
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
320 E North Ave
Pittsburgh, PA, 15212
Phone (412) 359-3291
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
1,838 services
Medicare patients, 2024
23
Average age 70
Drug cost, 2024
$5.5M
1,341 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Vida Jahangiri prescribed most often to Medicare patients was Anastrozole, with 194 prescriptions and refills. In total Vida Jahangiri wrote 1,341 Medicare prescriptions that cost $5.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 194 | 584 | 62 | $5,448 |
| Lenalidomide Generic | 62 | 62 | 14 | $684K |
| Letrozole Generic | 50 | 144 | 18 | $978 |
| Tamoxifen Citrate Generic | 50 | 167 | 16 | $1,382 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 45 | 45 | 12 | $699 |
| Hydroxyurea Generic | 45 | 111 | Under 11 | $1,639 |
| Xtandi Enzalutamide | 39 | 39 | Under 11 | $433K |
| Acyclovir Generic | 39 | 75 | 12 | $896 |
| Ondansetron Odt Ondansetron | 37 | 37 | 25 | $570 |
| Ibrance Palbociclib | 36 | 36 | Under 11 | $554K |
| Kisqali Ribociclib Succinate | 33 | 33 | Under 11 | $426K |
| Potassium Chloride Generic | 33 | 52 | Under 11 | $782 |
| Dexamethasone Generic | 33 | 45 | 19 | $556 |
| Prednisone Generic | 30 | 36 | 12 | $313 |
| Tagrisso Osimertinib Mesylate | 30 | 30 | Under 11 | $517K |
Brand drugs: 326 claims; generic drugs: 1,015 claims; opioid claims: 103.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Vida Jahangiri were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.